|
Woodcock: CDER to Publish Guidance on Postmarket Tracked Safety Issues
CDER plans to issue guidance on how it assesses the relative urgency of postmarket tracked safety issues (TSIs) for drugs so it can better direct resources toward those that pose the greatest risk, CDER Director Janet Woodcock says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives